MedTrace Logo

Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery

NCT00458549 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 232

Last updated 2018-07-13

No results posted yet for this study

Summary

RATIONALE: Polyunsaturated fatty acids are important for normal growth and development. One type, called omega-3 fatty acids (found in fish, fish oil, and some other foods), may affect the growth of prostate cancer.

PURPOSE: This randomized clinical trial is studying polyunsaturated fatty acids in treating patients with prostate cancer undergoing prostate biopsy and/or surgery.

Conditions

Interventions

DIETARY_SUPPLEMENT

omega-3 fatty acids

omega-3 fatty acids Oral 8g once a day for 21 days prior to (biopsy) surgery

PROCEDURE

biopsy

Sponsors & Collaborators

Principal Investigators

  • Jose A. Halperin, MD · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-27
Primary Completion
2009-05-14
Completion
2012-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00458549 on ClinicalTrials.gov